Understanding the Current Role and Future Application of Extracorporeal Life Support in Acute Respiratory Distress Syndrome

Darya Rudym¹, Kathleen E Melville¹, Matthew J Cummings¹, Darryl Abrams^{1

2}

Affiliations

¹ Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Vagelos College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, New York; and.
² Center for Acute Respiratory Failure, Columbia University Medical Center, New York, New York.

Comment

Darya Rudym et al. Am J Respir Crit Care Med. 2019.

. 2019 Oct 15;200(8):1057-1059.

doi: 10.1164/rccm.201904-0814RR.

Darya Rudym¹, Kathleen E Melville¹, Matthew J Cummings¹, Darryl Abrams^{1

2}

¹ Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Vagelos College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, New York; and.
² Center for Acute Respiratory Failure, Columbia University Medical Center, New York, New York.

No abstract available

Comment on

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial.
Goligher EC, Tomlinson G, Hajage D, Wijeysundera DN, Fan E, Jüni P, Brodie D, Slutsky AS, Combes A. Goligher EC, et al. JAMA. 2018 Dec 4;320(21):2251-2259. doi: 10.1001/jama.2018.14276. JAMA. 2018. PMID: 30347031
Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis.
Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Munshi L, et al. Lancet Respir Med. 2019 Feb;7(2):163-172. doi: 10.1016/S2213-2600(18)30452-1. Epub 2019 Jan 11. Lancet Respir Med. 2019. PMID: 30642776
Feasibility and safety of extracorporeal CO₂ removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study.
Combes A, Fanelli V, Pham T, Ranieri VM; European Society of Intensive Care Medicine Trials Group and the “Strategy of Ultra-Protective lung ventilation with Extracorporeal CO2 Removal for New-Onset moderate to severe ARDS” (SUPERNOVA) investigators. Combes A, et al. Intensive Care Med. 2019 May;45(5):592-600. doi: 10.1007/s00134-019-05567-4. Epub 2019 Feb 21. Intensive Care Med. 2019. PMID: 30790030

1. Goligher EC, Tomlinson G, Hajage D, Wijeysundera DN, Fan E, Jüni P, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA. 2018;320:2251–2259. - PubMed
1. Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. EOLIA Trial Group, REVA, and ECMONet. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965–1975. - PubMed
1. Bland JM, Altman DG. Bayesians and frequentists. BMJ. 1998;317:1151–1160. - PMC - PubMed
1. Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiol. 2009;62:13–21. e5. - PubMed
1. Lewis RJ, Angus DC. Time for clinicians to embrace their inner Bayesian? Reanalysis of results of a clinical trial of extracorporeal membrane oxygenation. JAMA. 2018;320:2208–2210. - PubMed